TL;DR — Hormonal, immune, and paracrine signaling networks desync with age; SASPSenescence-Associated Secretory Phenotype — the inflammatory cocktail of cytokines, proteases, and growth factors secreted by senescent (zombie) cells. Full glossary → from senescent cells hijacks normal cell-to-cell talk. NRF2 anti-inflammatory stack and circadian-aligned sleep are primary levers. Track IL-6 proxies (hs-CRP), insulin sensitivity, and cortisol rhythm — this hallmark amplifies every other one.
What this hallmark means
Cells coordinate through hormones, cytokines, neurotransmitters, and direct contact signaling. Aging disrupts every channel: neuroendocrine output declines (GH, sex hormones), insulin resistance spreads, and senescent SASP cells broadcast inflammatory damage signals that neighbors obey.
Poor intercellular communication does not stay local — it amplifies inflammation (H10), senescence (H7), and mitochondrial stress (H6).
| Failure mode | What changes | What you feel |
|---|---|---|
| SASP paracrine hijack | Senescent cells poison local environment | Fatigue, mood swings, "inflammation without cause" |
| Insulin resistance | Metabolic hormones desync | Blood sugar swings, visceral fat |
| Circadian misalignment | Cortisol/melatonin/GH pulses flatten | Poor sleep, low morning energy |
| Neuroendocrine decline | GH, thyroid, sex hormone drift | Recovery slowdown, libido/mood changes |
Hallmark 9 · Altered intercellular communication
An amplifier hallmark — rarely primary, but accelerates all others. Fixing SASP source (senescence + inflammation) beats symptom-chasing. TNiC coverage 55%.
Why this matters for your protocol
When "everything feels off" but individual labs are borderline, suspect signaling desync — especially if hs-CRP is modestly elevated and sleep is irregular.
Intervention hierarchy (evidence-weighted):
- Anti-inflammatory stack (NRF2A protein that turns on 200+ antioxidant and detox genes when activated. Full glossary →) — sulforaphane + GlyNAC reduce SASP-driven disruption at source
- Resveratrol (NF-κB modulation) — inhibits inflammatory transcription amplifiers
- Sleep / circadian alignment — melatonin, cortisol, GH pulses coordinate repair
- Insulin sensitivity optimization — metabolic health is master hormone regulator
- Senolytic clearance — removes SASP-secreting cells (clinical, Tier B)
Circadian misalignment disrupts cortisol, melatonin, and growth hormone pulses — all master intercellular coordinators. Sulforaphane NRF2 activation suppresses NF-κB inflammatory transcription (PMID 38772511), reducing SASP-amplified signaling noise.
Practical intervention map
| Lever | Mechanism | Evidence | TNiC resource |
|---|---|---|---|
| GlyNAC + sulforaphane | NRF2 → ↓ NF-κB / SASP | Tier A | NRF2 Triad |
| Resveratrol PM | SIRT1 + NF-κB modulation | Tier B | Resveratrol |
| Sleep consistency | Hormone pulse restoration | Tier A | Sleep |
| TRE + Zone 2 | Insulin sensitivity | Tier A | Nutrition · Exercise |
| Senescence targeting | ↓ SASP source | Tier B | Cellular senescence |
← Swipe for more columns →
Your 90-day signaling restoration protocol
Weeks 1–4: Lock wake time ±30 min. Log hs-CRP baseline. Audit fasting glucose and subjective mood/social energy.
Weeks 5–8: Start GlyNAC 600/600 AM. Add 150 min/week Zone 2 for insulin sensitivity.
Weeks 9–12: Add sulforaphane + R-ALA per NRF2 Triad if CRP >1.0 or signaling symptoms persist.
Decision point at week 12: hs-CRP ↓30% and sleep score improved → continue. Flat → hormone panel (thyroid, testosterone/estradiol as appropriate) with physician.
Which signaling path first?
hs-CRP >1.0 mg/L or persistent brain fog + mood volatility?
node | On immunosuppressants or active autoimmune flare?
redflag | Rheumatologist coordination — NRF2 stack is adjunct only
Start NRF2 Triad ramp → add resveratrol week 8 if on NAD+ stack
node | Sleep irregular (wake time varies >60 min) or fasting glucose >100?
Maintain surveillance; annual hormone panel if age 45+
CRP >10 mg/L, fever, or rapid unexplained weight change — acute pathology workup first
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
What to measure
| Signal | Type | Frequency | Success looks like |
|---|---|---|---|
| hs-CRP | Lab | Baseline, 12 wk, quarterly | <1.0 mg/L |
| Fasting glucose / HOMA-IR | Lab | Baseline, 12 wk | Glucose <100; IR improving |
| Cortisol rhythm | Lab (optional) | AM sample | Appropriate AM peak |
| Sleep consistency | Wearable | Daily | Wake SD <30 min |
| Mood / social energy | Subjective | Weekly | Stable or ↑ trend |
← Swipe for more columns →
hs-CRP (mg/L)
1–3
Wake time SD (min)
>60
Social energy (1–10)
≤5
hs-CRP (mg/L)
<1.0
Wake time SD (min)
<30
Social energy (1–10)
≥7
Track signaling biomarkers
Log hs-CRP, fasting glucose, and optional hormone panel at baseline and week 12.
Open Labs hubRed flags — when to pause or escalate
Stop and consult before intensifying
- Active autoimmune flare or immunosuppressive therapy — anti-inflammatory stacks need specialist coordination
- New-onset diabetes or HbA1c ≥6.5% — insulin signaling requires medical management first
- Depression with suicidal ideation — psychiatric care before supplement escalation; HPA axis is not a DIY fix
Synergies worth knowing
| Stack | Covers | Best for |
|---|---|---|
| NRF2 Triad | SASP + NF-κB source | Elevated CRP + fog |
| SIRT1 pair | Metabolic + epigenetic signaling | NAD+ decline + insulin drift |
| Sleep + Stress | Circadian hormone pulses | Irregular schedule |
Build your stack
Stack Architect flags signaling conflicts — enable sleep pillar before adding NRF2 legs for synergyWhen two compounds together produce greater effect than either alone. Full glossary → score boost.
Open Stack ArchitectPersonal results template
My intercellular communication log
| Date | Week | hs-CRP | Fasting glucose | Sleep (h) | Mood (1–10) | Social energy (1–10) | Notes |
|---|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | — | Baseline |
| YYYY-MM-DD | 8 | — | — | — | — | — | NRF2 ramp |
| YYYY-MM-DD | 12 | — | — | — | — | — | Primary endpoint |
← Swipe for more columns →
Personal response criteria: - Meaningful: hs-CRP <1.0 + wake SD <30 min + mood stable ↑ - Plateau: Hormone panel with physician before dose escalation - Adverse: New joint swelling, rash, or fever → stop stack, rule out flare
Further reading
- Campisi — SASP and paracrine senescence spreading
- Sulforaphane NRF2-NF-κB crosstalk (PMID 38772511)
- Cellular senescence — SASP source hallmark
References
- See PMID registry. Sulforaphane upregulates NRF2 and NQO1 in CKD patients. Free Radic Biol Med (2024). PMID 38772511
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.